$VSEC

VSEC Maintained by Morgan Stanley -- Price Target Lowered to $21

Morgan Stanley maintained VSE Corp (VSEC) at Equal-Weight but lowered its price target from $245 to $215. The company's stock is currently trading at $160.56, which is 17% above its GF Value™ of $137.24. VSEC has a GF Score™ of 82/100, indicating strong overall performance, but shows signs of insider selling and mixed institutional activity.

Original reporting
Published Oct 19, 2026, 6:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 6:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$VSEC
Bearish
high confidence
Mentioned
$VSEC
Relevance
7/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$VSECBearishMed
01

Why it matters

Analyst downgrade may trigger short‑term sell‑offs, but long‑term fundamentals remain mixed.

02

Market read

The rating change is the primary new information, offering a short‑term trading signal.

03

What to watch

Insider selling and mixed guru activity may signal deeper concerns beyond the analyst's view.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

VSEC operates in the aerospace and defense aftermarket services sector with a $4.5B market cap.

Company-level read

Ticker impact

$VSECBearishHigh confidence
Context

Morgan Stanley lowered VSEC's price target to $215 from $245, indicating a more cautious outlook.

Expected impact

likely downward pressure as the market prices in the lower target

Evidence & confidence

Analyst price‑target reductions historically lead to short‑term sell pressure, especially when the cut is ~12%.

Market effects

A cautious outlook may weigh on other aerospace & defense stocks.

Limited to U.S. industrials investors.

Modest; primarily affects VSEC and peers.

Counterpoint

If the broader sector remains strong, the target cut could be an overreaction.

Key entities

  • Morgan Stanley

    Provided the rating update and price‑target cut.

Related articles

$VSECMed

Guggenheim initiates VSE stock with neutral on margin concerns

Guggenheim initiated VSE Corporation (VSEC) with a neutral rating, citing margin concerns and the need for operational improvements. The company reported Q2 2026 earnings of $1.75 per share on $449.1M revenue, beating estimates. Stifel raised its price target to $260, maintaining a Buy rating. VSEC's EBITDA grew 98% YoY to $86M, with margins expanding to 19.2%.

$VSECMedAI 8/10

A Record Quarter Raises The Stakes For VSE Corp. (VSEC)

VSE Corporation (VSEC) reported Q2 revenue of $449.1M, up 65% YoY, with organic growth of 14%. Adjusted EBITDA rose to $86.0M, with a margin of 19.2%. The company completed two major acquisitions, raising full-year guidance. Debt increased to $966.7M, and free cash flow was negative $50.0M for H1 2026. The stock trades at 25x forward earnings.

$VSECMed

VSE (VSEC) Q2 2026 Earnings Call Transcript

VSE Corp (VSEC) Q2 2026 earnings call said it delivered record revenue and profitability. Revenue rose to $449 million, up 65% YoY, with 14% organic growth. Adjusted EBITDA was $86 million, up 98% YoY, and margin reached a record 19.2%. VSE said it closed the PAG deal May 5 (~$2B) and NorthStar on April 1, and raised full-year revenue and margin guidance.

$VSECMedAI 8/10

VSE Q2 Earnings Call Highlights

VSE Corp (NASDAQ:VSEC) reported Q2 adjusted net income of $55 million (+101% YoY) and adjusted diluted EPS of $1.75 (+33%). Management said MRO revenue rose 149% YoY and distribution revenue grew 17%. VSE raised full-year 2026 outlook to 61% to 64% revenue growth and 18.7% to 19% adjusted EBITDA margin. Free cash flow was about $19 million.